This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6pjo
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==HIV-1 Protease NL4-3 WT in Complex with LR2-42== | ==HIV-1 Protease NL4-3 WT in Complex with LR2-42== | ||
| - | <StructureSection load='6pjo' size='340' side='right'caption='[[6pjo]]' scene=''> | + | <StructureSection load='6pjo' size='340' side='right'caption='[[6pjo]], [[Resolution|resolution]] 1.95Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PJO OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6PJO FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6pjo]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PJO OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6PJO FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6pjo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6pjo OCA], [http://pdbe.org/6pjo PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6pjo RCSB], [http://www.ebi.ac.uk/pdbsum/6pjo PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6pjo ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=OQ7:methyl+[(1S)-1-cyclopentyl-2-({(2S,4S,5S)-5-[({[(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]oxy}carbonyl)amino]-4-hydroxy-1,6-diphenylhexan-2-yl}amino)-2-oxoethyl]carbamate'>OQ7</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">pol ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6pjo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6pjo OCA], [http://pdbe.org/6pjo PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6pjo RCSB], [http://www.ebi.ac.uk/pdbsum/6pjo PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6pjo ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C2-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2' position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2' position without significantly affecting potency. However, the group on the opposite P2/P2' position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights for optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres. | ||
| + | |||
| + | Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-Tetrahydrofuran in a Pseudo-Symmetric Dipeptide Isostere.,Rusere LN, Lockbaum GJ, Henes M, Lee SK, Spielvogel E, Rao DN, Kosovrasti K, Nalivaika EA, Swanstrom R, Kurt Yilmaz N, Schiffer CA, Ali A J Med Chem. 2020 Jul 16. doi: 10.1021/acs.jmedchem.0c00529. PMID:32672965<ref>PMID:32672965</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 6pjo" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Ali A]] | + | [[Category: Ali, A]] |
| - | [[Category: Henes M]] | + | [[Category: Henes, M]] |
| - | [[Category: Kosovrasti K]] | + | [[Category: Kosovrasti, K]] |
| - | [[Category: KurtYilmaz N]] | + | [[Category: KurtYilmaz, N]] |
| - | [[Category: Lee | + | [[Category: Lee, S K]] |
| - | [[Category: Lockbaum | + | [[Category: Lockbaum, G J]] |
| - | [[Category: Nalivaika | + | [[Category: Nalivaika, E A]] |
| - | [[Category: Rusere | + | [[Category: Rusere, L N]] |
| - | [[Category: Schiffer | + | [[Category: Schiffer, C A]] |
| - | [[Category: Spielvogel E]] | + | [[Category: Spielvogel, E]] |
| - | [[Category: Swanstrom R]] | + | [[Category: Swanstrom, R]] |
| + | [[Category: Drug resistance]] | ||
| + | [[Category: Hiv]] | ||
| + | [[Category: Hydrolase]] | ||
| + | [[Category: Hydrolase inhibitor complex]] | ||
| + | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
| + | [[Category: Nl4-3 protease]] | ||
| + | [[Category: Protease inhibitor]] | ||
Revision as of 11:25, 26 August 2020
HIV-1 Protease NL4-3 WT in Complex with LR2-42
| |||||||||||
Categories: Large Structures | Ali, A | Henes, M | Kosovrasti, K | KurtYilmaz, N | Lee, S K | Lockbaum, G J | Nalivaika, E A | Rusere, L N | Schiffer, C A | Spielvogel, E | Swanstrom, R | Drug resistance | Hiv | Hydrolase | Hydrolase inhibitor complex | Hydrolase-hydrolase inhibitor complex | Nl4-3 protease | Protease inhibitor
